ITH Finalizes Acquisition by H.I.G. Capital

H.I.G. Capital, a notable global alternative investment firm, has completed the acquisition of ITH Group Limited. ITH, founded by Adam Bloom and Karen Hamling, is a UK company specializing in aseptic preparation services for tailored injectable medications, focusing on unmet medical needs. Post-acquisition, Bloom and Hamling will maintain their roles as CEO and COO, respectively. The company is recognized for its leadership in the compounding sector, particularly in chemotherapy, total parenteral nutrition, and intravenous additives. The deal aims to support ITH’s organic growth and enhance its production capacity. John Harper, of H.I.G., expressed enthusiasm about expanding the capabilities of ITH, which serves both private and NHS clients. Financial terms of the transaction were not disclosed, but it aligns with H.I.G.’s strategy of investing in valuable growth opportunities, bolstered by its extensive resources.